Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS
Journal of Clinical Oncology · 20.06.2026 · 44 (18) · 1747-1748
DOI: 10.1200/jco-25-02755 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.06.2026. Verfasst von Jian Huang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Jian Huang, MD, PhD, Clinical Laboratory Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China; and Zheng-Fu Xie, MD, P…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Jian Huang, MD, PhD, Clinical Laboratory Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China; and Zheng-Fu Xie, MD, PhD, Geriatrics Department, The First Affiliated Hospital of Guangxi Me…
ORCID-Profile: Jian Huang, Zheng-Fu Xie
Zitieren
APA
Huang, J., & Xie, Z. F. (2026). Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS. Journal of Clinical Oncology, 44(18), 1747-1748. https://doi.org/10.1200/jco-25-02755
Vancouver
Huang J, Xie ZF. Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS. Journal of Clinical Oncology. 2026;44(18):1747-1748. doi:10.1200/jco-25-02755
BibTeX
@article{Huang2026,
author = {Huang, Jian and Xie, Zheng-Fu},
title = {Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {18},
pages = {1747--1748},
doi = {10.1200/jco-25-02755}
}
EUVIMED